Schizophrenia - Clinical Case (21-Year-Old Male)
Q2. Clinical Findings Supporting Schizophrenia (DSM-5-TR)
DSM-5-TR Criterion A - At least 2 of the following for ≥1 month:
Positive Symptoms (excess of normal functions - dramatic, easily recognized):
| Finding in Case | Symptom Type | How It Supports Diagnosis |
|---|
| Alien invasion delusions + belief transmitters are implanted in his brain | Delusions (bizarre) | Fixed false beliefs unresponsive to reason - a core Criterion A symptom |
| "They can read our thoughts" | Thought broadcasting | Classic first-rank symptom |
| Repeating scripted phrases in the ED - "decipher the alien code" | Disorganized speech / perseveration | Reflects thought process disorganization |
| Lining walls with aluminum foil; building "interstellar deflectors" | Grossly disorganized behavior | Bizarre, goal-directed but reality-disconnected actions |
Negative Symptoms (deficit of normal functions - subtle but disabling):
| Finding in Case | Symptom Type |
|---|
| Locked himself in room for ~1 year, refused meals outside | Social withdrawal / avolition |
| Mute for prolonged periods in the ED, staring straight ahead | Alogia + affective blunting |
| Dropped out of all college classes | Avolition (loss of goal-directed behavior) |
| Fired from job after bizarre behavior | Functional deterioration |
"The feature most suggestive of schizophrenia is the presence of both positive AND negative symptoms together." - Swanson's Family Medicine Review
DSM-5-TR Criterion B - Functional deterioration:
He dropped out of college, lost his job, and stopped self-care - clear decline from premorbid baseline in work, social, and self-care domains.
DSM-5-TR Criterion C - Duration ≥6 months:
Symptoms began ~1 year ago (gradual prodrome of withdrawal) with acute psychotic break ~1 week ago. Total duration exceeds 6 months. Active-phase symptoms have been present >1 month.
DSM-5-TR Exclusions met:
- No mood episode is predominant
- Father denies any substance use
- Physical exam and vitals are normal (no organic cause suggested)
Q5. Differential Diagnoses - Why Schizophrenia Wins
| Diagnosis | Why It Was Considered | Why It's Ruled Out |
|---|
| Schizophreniform Disorder | Identical symptoms to schizophrenia | Ruled out because total symptom duration is ~12 months (>6 months). Schizophreniform requires <6 months total |
| Schizoaffective Disorder | Has psychosis | Requires prominent depressive or manic symptoms as a consistent feature alongside psychosis. No mood episodes described in this case. Father reports no mood changes. |
| Bipolar Disorder (Manic with Psychosis) | Psychosis present | Bipolar psychosis occurs only DURING mood episodes. Here there's no euphoria, grandiosity cycling, or euthymic periods without psychosis. Psychosis is sustained and primary. |
| Delusional Disorder | Has delusions for >1 month | Delusional disorder requires absence of prominent hallucinations, bizarre behavior, and disorganized speech. This patient has ALL of these. Also, his delusions ARE bizarre (alien transmitters in brain) - delusional disorder typically has non-bizarre delusions. |
| Brief Psychotic Disorder | Sudden-onset psychosis | Duration must be <1 month with full return to premorbid function. His illness is ~1 year old with progressive deterioration - does not fit. |
| Substance-Induced Psychosis | Psychosis present | Father firmly denies any drug use. Gradual 1-year prodrome doesn't fit acute substance-induced picture. Physical exam normal. |
| Psychosis from Medical Condition | Always exclude | Normal vitals, normal physical exam. No neurological signs found. CT requested by patient but no clinical indication of organic pathology. |
Bottom line: Only schizophrenia explains the full triad of prolonged duration, both positive and negative symptoms, profound functional decline, and absence of a mood or organic cause.
Q3. Diagnostic Workup - What to Order and Why
Even with a clear clinical picture, workup is mandatory to rule out organic causes and establish a safe treatment baseline.
Immediately in the ED:
| Test | Rationale |
|---|
| CBC | Rule out infection, anemia - can mimic or worsen psychosis |
| Comprehensive metabolic panel (CMP) | Rule out hepatic encephalopathy, renal failure, electrolyte disturbances (hyponatremia causes psychosis) |
| Thyroid function (TSH, T4) | Hypothyroidism and hyperthyroidism both cause psychosis |
| Blood glucose | Hypoglycemia is a common reversible cause of altered behavior |
| Urine drug screen | Must objectively confirm father's claim of no substance use. Stimulants, cannabis, PCP all cause psychosis. |
| Urine/serum toxicology | Rule out heavy metals, carbon monoxide in unusual presentations |
| Serum B12 and folate | Deficiency causes neuropsychiatric symptoms |
| HIV, RPR (syphilis) | Both cause organic psychosis - often missed |
| Urinalysis | Infection (especially in young men) can precipitate psychosis |
CT Head (non-contrast):
The patient himself is requesting a CT - while his reasoning is delusional, clinical indication exists to rule out space-occupying lesion, intracranial hemorrhage, or structural abnormality. Result likely normal, which helps confirm functional (psychiatric) origin.
MRI Brain (follow-up, not urgent):
More sensitive than CT for subtle structural changes. Studies show enlarged ventricles and reduced gray matter in schizophrenia - helpful for longitudinal documentation, not for acute diagnosis.
EEG:
Indicated if there is any suspicion of temporal lobe epilepsy, which can produce complex paranoid ideation and automatisms resembling psychosis.
Baseline before starting antipsychotics:
- Fasting lipids and glucose (metabolic syndrome risk with SGAs)
- ECG - QTc baseline before initiating medication
- Prolactin level (baseline before risperidone/haloperidol)
- Weight and BMI
- Blood pressure
How results influence management: If all labs are normal, confidence in a primary psychiatric diagnosis is high. If a metabolic or toxic cause is found, that takes priority over antipsychotic initiation.
Q4. Pharmacologic and Non-Pharmacologic Treatment + Monitoring
Pharmacologic - First Episode, First Choice
Start with a Second-Generation Antipsychotic (SGA):
Preferred agents for a first episode:
- Risperidone 2-4 mg/day (titrate slowly) - good evidence, available as long-acting injectable later
- Olanzapine 10 mg/day - excellent for agitation, but higher metabolic risk
- Aripiprazole - better metabolic profile, useful if weight is a concern
Why SGAs first? They block D2 receptors (antipsychotic effect) AND serotonin 5-HT2A receptors (reduces EPS). They are less likely to cause tardive dyskinesia than first-generation agents like haloperidol.
Benefits:
- Reduce positive symptoms (delusions, hallucinations) within 2-6 weeks
- Reduce agitation rapidly (often within hours)
- Improve social functioning over time
Adverse effects to monitor:
| Adverse Effect | Drug Most Likely | Monitoring |
|---|
| Weight gain, dyslipidemia, hyperglycemia (metabolic syndrome) | Olanzapine > Quetiapine > Risperidone | Fasting glucose, lipids, weight - at baseline, 3 months, then yearly |
| Hyperprolactinemia (gynecomastia, amenorrhea) | Risperidone, Haloperidol | Serum prolactin if symptomatic |
| EPS (akathisia, parkinsonism) | All antipsychotics | AIMS scale at each visit |
| Tardive dyskinesia (long-term) | All antipsychotics | AIMS scale every 6-12 months |
| QTc prolongation | Ziprasidone, Haloperidol | Repeat ECG after dose titration |
| Sedation | Quetiapine, Olanzapine | Clinical assessment |
If no response after 6-8 weeks at adequate dose: Switch to another SGA. If two adequate SGA trials fail, consider Clozapine - the gold standard for treatment-resistant schizophrenia. Requires mandatory WBC/ANC monitoring due to agranulocytosis risk.
If acute agitation: Oral lorazepam 1-2 mg as adjunct. IM haloperidol + lorazepam if patient is refusing oral medication and dangerous.
Non-Pharmacologic Interventions
-
Psychoeducation - Teach the patient (when stable) and family about schizophrenia, its course, the need for medication, and early warning signs of relapse.
-
Cognitive Behavioral Therapy for Psychosis (CBTp) - Helps patient develop coping strategies for residual symptoms. Does not cure psychosis but reduces distress and improves insight.
-
Social Skills Training - Addresses the interpersonal deficits caused by negative symptoms.
-
Supported Employment (Individual Placement and Support - IPS model) - This patient had a job; he can potentially return to work. Competitive employment with job coaching improves outcomes.
Monitoring Treatment Response
Use validated scales:
- PANSS (Positive and Negative Syndrome Scale) - gold standard
- BPRS (Brief Psychiatric Rating Scale) - shorter, widely used
- Assess at 2 weeks, 4 weeks, 8 weeks initially, then every 3 months
Signs of response: decreased agitation, reduction in delusional preoccupation, re-engagement with family, improving sleep, patient beginning to express doubt about alien beliefs.
Q1. Comprehensive Management Plan
Immediate Safety - Emergency Department
- Psychiatric hold / voluntary/involuntary admission - He is a danger to himself and lacks insight. Hospitalization is justified and necessary.
- Remove items that could be used for self-harm - Include checking for weapons concealed in the aluminum foil.
- 1:1 observation - Given agitation and psychosis severity.
- Do NOT attempt to argue with or confront delusions - This escalates distress. Approach calmly: "You seem very upset, let us help keep you safe."
- Medical clearance first - Run the labs listed in Q3 before psychiatric admission.
Acute Inpatient Phase (Days 1-14)
- Start SGA (risperidone 2 mg BID or olanzapine 10 mg QHS)
- Adjunct lorazepam PRN for agitation
- Daily clinical assessment
- Establish therapeutic alliance
- Engage parents in family meetings - explain diagnosis, treatment plan, what to expect
Subacute Phase (Weeks 2-6, continued inpatient or step-down)
- Titrate antipsychotic to therapeutic dose
- Begin psychoeducation sessions (patient + family)
- Occupational therapy assessment
- Social work referral for housing, disability, community services
- Screen for depression (10-15% of schizophrenia patients have comorbid depression; suicide risk is 10-13% lifetime)
Family Involvement - Critical
- Family psychoeducation reduces relapse rates significantly
- Teach family about Expressed Emotion (EE) - high criticism and emotional over-involvement in the home increase relapse risk
- Encourage low-stress home environment
- Include family in discharge planning
Relapse Prevention
- Medication adherence is the single biggest modifiable risk factor for relapse
- Consider Long-Acting Injectable (LAI) antipsychotic once stable - e.g., risperidone microspheres (Risperdal Consta) every 2 weeks. LAIs eliminate the covert non-adherence problem.
- Identify personal early warning signs (prodromal signals): sleep disruption, social withdrawal, re-emergence of paranoid ideas
- Create a Relapse Prevention Plan with patient and family - written, simple, actionable
Occupational Rehabilitation
- Connect with Individual Placement and Support (IPS) vocational program
- Goal: return to some form of education or part-time employment when stable
- Avoid pressuring early - premature high demands worsen outcomes
- College return may be possible with accommodations (reduced course load, mental health counselor at campus)
Community Resources
- Assertive Community Treatment (ACT) team if available - mobile, multidisciplinary team for high-risk patients
- NAMI (National Alliance on Mental Illness) support groups for family
- Crisis hotline education for family
- Case manager assigned for medication, appointments, benefits navigation
Follow-Up Schedule
| Phase | Frequency | Purpose |
|---|
| Post-discharge (first month) | Weekly outpatient visits | Medication tolerance, early relapse detection |
| Months 2-6 | Biweekly | Dose adjustment, psychosocial engagement |
| Stable phase (6 months onward) | Monthly then every 3 months | Metabolic monitoring, adherence, functional outcomes |
| Annual | Comprehensive review | AIMS scale, metabolic labs, medication reassessment |
Justification for each component: Schizophrenia is a chronic, biologically-driven illness with high relapse rates (50-80% within 5 years without maintenance treatment). The combination of antipsychotic medication + psychosocial support + family engagement consistently produces better functional outcomes than medication alone. Active monitoring prevents the two leading causes of early death in schizophrenia - suicide (10-13% lifetime risk) and metabolic complications of antipsychotic treatment.
Sources: Kaplan & Sadock's Comprehensive Textbook of Psychiatry; Swanson's Family Medicine Review; Goodman & Gilman's Pharmacological Basis of Therapeutics; The Maudsley Prescribing Guidelines 15ed